🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?

Recruitingn/aAges 18 Years - anyAllFundación para la Investigación del Hospital Clín…
NCT06582342 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Prospective multicenter study in which all patients with borderline or locally advanced pancreatic adenocarcioma undergoing neoadjuvant chemotherapy and surgical exploration with curative intent will be included for one year. Preoperative images by traditional CT and 3D-MSP technology will be evaluated, comparing the accuracy variables (sensitivity, specificity, predictive values, area under the curve, concordance index) of both techniques with the gold standard (results of surgery and histopathological analysis).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: \- Patients with a diagnosis of borderline or locally advanced PAC of the head of the pancreas, as defined by the National Comprehensive Cancer Network (NCCN), who have received neoadjuvant treatment and who undergo surgical exploration with resective intent. Exclusion Criteria: * Patients younger than 18 years of age. * Patients under 18 years of age. * Disease progression during neoadjuvant treatment. * No preoperative CT scan. * Refusal to participate in the study.
💊

What it tests

  • Three dimensional imaging technology (3D-PANC MSP model)
  • Computerized tomography group (conventional CT)
📍

Where

17 sites
Hospital General de Alicante
Alicante, Spain
Hospital Universitario de Badajoz
Badajoz, Spain
Hospital del Mar (Barcelona)
Barcelona, Spain
Hospital Clínic de Barcelona
Barcelona, Spain
Hospital de Bellvitge
Barcelona, Spain
Hospital German Trias y Puyol
Barcelona, Spain
Hospital Nuestra señora de la Candelaria
Candelaria, Spain
Hospital General de Castellón
Castellon, Spain

…and 9 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy